|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02877 SHINEWAY PHARM
Nominal 
8.330 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 10.890% | 9.365% | 7.722% | 4.113% | 7.259% |
| ROAE (%) | 14.452% | 11.768% | 9.519% | 5.099% | 8.718% |
| Return on Capital Employed (%) | 13.578% | 11.007% | 9.117% | 4.902% | 8.452% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 75.149% | 74.376% | 74.773% | 74.852% | 73.229% |
| EBITDA Margin (%) | 26.747% | 22.374% | 21.403% | 14.044% | 22.758% |
| Pre-tax Profit Margin (%) | 27.460% | 23.212% | 22.339% | 14.875% | 23.754% |
| Net Profit Margin (%) | 21.466% | 18.295% | 17.269% | 11.109% | 18.594% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 3.351 X | 4.072 X | 5.189 X | 4.620 X | 4.417 X |
| Quick Ratio (X) | 2.982 X | 3.677 X | 4.653 X | 4.249 X | 4.051 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 26.522% | 22.466% | 18.080% | 19.676% | 18.992% |
| Total Debt / Total Assets (%) | 3.147% | 0.090% | 0.207% | 5.436% | 5.673% |
| Net Debt / Total Assets (%) | -58.361% | -60.968% | -58.174% | -49.225% | -49.661% |
| Total Debt / Shareholders' Funds (%) | 4.283% | 0.117% | 0.253% | 6.768% | 7.003% |
| Long Term Debt / Shareholders' Funds (%) | 0.005% | 0.014% | 0.124% | 0.259% | 0.026% |
| Net Debt / Shareholders' Funds (%) | -79.426% | -78.634% | -71.013% | -61.283% | -61.304% |
| Net Cash / (Debt) ($) | 5.587B | 5.019B | 4.191B | 3.551B | 3.541B |
| Net Cash / (Debt) per share ($) | 6.756 | 6.069 | 5.067 | 4.294 | 4.282 |
| Total Debt / Capital Employed (%) | 4.220% | 0.113% | 0.244% | 6.515% | 6.795% |
| Interest Coverage Ratio (X) | 454.143 X | 1456.595 X | 575.245 X | 24.797 X | 242.825 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 252.895 Day | 224.558 Day | 231.365 Day | 238.778 Day | 210.682 Day |
| Receivables Turnover (Day) | 90.327 Day | 83.162 Day | 89.782 Day | 98.611 Day | 81.324 Day |
| Payables Turnover (Day) | 32.064 Day | 24.824 Day | 22.249 Day | 24.315 Day | 27.149 Day |
| Remarks: | Real time quote last updated: 15/11/2024 09:25 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 626,479 |
| %Change | 27.472% |
| EPS / (LPS) | RMB 0.830 |
| NBV Per Share (¥) | RMB 8.871 |